WO2012123869A2 - Device for optical nerve localization and optical nerve stimulation - Google Patents
Device for optical nerve localization and optical nerve stimulation Download PDFInfo
- Publication number
- WO2012123869A2 WO2012123869A2 PCT/IB2012/051111 IB2012051111W WO2012123869A2 WO 2012123869 A2 WO2012123869 A2 WO 2012123869A2 IB 2012051111 W IB2012051111 W IB 2012051111W WO 2012123869 A2 WO2012123869 A2 WO 2012123869A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- optical
- roi
- radiations
- localization
- nervous tissue
- Prior art date
Links
- 230000003287 optical effect Effects 0.000 title claims abstract description 157
- 230000004807 localization Effects 0.000 title claims abstract description 45
- 210000005036 nerve Anatomy 0.000 title abstract description 33
- 230000007383 nerve stimulation Effects 0.000 title abstract description 6
- 239000000523 sample Substances 0.000 claims abstract description 71
- 230000000638 stimulation Effects 0.000 claims abstract description 47
- 238000000034 method Methods 0.000 claims abstract description 28
- 230000005855 radiation Effects 0.000 claims description 85
- 239000012530 fluid Substances 0.000 claims description 43
- 238000001727 in vivo Methods 0.000 claims description 29
- 238000005286 illumination Methods 0.000 claims description 20
- 238000004611 spectroscopical analysis Methods 0.000 claims description 11
- 230000004936 stimulating effect Effects 0.000 claims description 11
- 238000011282 treatment Methods 0.000 claims description 8
- 238000004458 analytical method Methods 0.000 claims description 3
- 210000001519 tissue Anatomy 0.000 abstract description 82
- 210000000944 nerve tissue Anatomy 0.000 abstract description 55
- 238000012544 monitoring process Methods 0.000 abstract description 12
- 238000000149 argon plasma sintering Methods 0.000 abstract description 5
- 238000012795 verification Methods 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 description 20
- 239000000835 fiber Substances 0.000 description 17
- 238000001514 detection method Methods 0.000 description 14
- 239000013307 optical fiber Substances 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 239000011358 absorbing material Substances 0.000 description 11
- 230000008901 benefit Effects 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 230000004044 response Effects 0.000 description 9
- 238000002679 ablation Methods 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 102000001554 Hemoglobins Human genes 0.000 description 5
- 108010054147 Hemoglobins Proteins 0.000 description 5
- 230000003595 spectral effect Effects 0.000 description 5
- 238000012790 confirmation Methods 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 108091006146 Channels Proteins 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 238000001069 Raman spectroscopy Methods 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000013532 laser treatment Methods 0.000 description 2
- 238000002324 minimally invasive surgery Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229910019655 synthetic inorganic crystalline material Inorganic materials 0.000 description 2
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- 108091005462 Cation channels Proteins 0.000 description 1
- 206010069808 Electrical burn Diseases 0.000 description 1
- 229910052691 Erbium Inorganic materials 0.000 description 1
- 108090000862 Ion Channels Proteins 0.000 description 1
- 102000004310 Ion Channels Human genes 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 238000001237 Raman spectrum Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- JNDMLEXHDPKVFC-UHFFFAOYSA-N aluminum;oxygen(2-);yttrium(3+) Chemical compound [O-2].[O-2].[O-2].[Al+3].[Y+3] JNDMLEXHDPKVFC-UHFFFAOYSA-N 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 210000003050 axon Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 210000001787 dendrite Anatomy 0.000 description 1
- 230000023077 detection of light stimulus Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- UYAHIZSMUZPPFV-UHFFFAOYSA-N erbium Chemical compound [Er] UYAHIZSMUZPPFV-UHFFFAOYSA-N 0.000 description 1
- 238000001506 fluorescence spectroscopy Methods 0.000 description 1
- 238000002189 fluorescence spectrum Methods 0.000 description 1
- 239000002223 garnet Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 238000003709 image segmentation Methods 0.000 description 1
- 238000002357 laparoscopic surgery Methods 0.000 description 1
- 238000000608 laser ablation Methods 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 229940005483 opioid analgesics Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 206010034674 peritonitis Diseases 0.000 description 1
- 239000004038 photonic crystal Substances 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000001055 reflectance spectroscopy Methods 0.000 description 1
- 238000002310 reflectometry Methods 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 239000010979 ruby Substances 0.000 description 1
- 229910001750 ruby Inorganic materials 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- -1 shells Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 210000001032 spinal nerve Anatomy 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 230000003685 thermal hair damage Effects 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 229910052727 yttrium Inorganic materials 0.000 description 1
- 229910019901 yttrium aluminum garnet Inorganic materials 0.000 description 1
- VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4887—Locating particular structures in or on the body
- A61B5/4893—Nerves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0075—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0077—Devices for viewing the surface of the body, e.g. camera, magnifying lens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0622—Optical stimulation for exciting neural tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/067—Radiation therapy using light using laser light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0062—Arrangements for scanning
- A61B5/0068—Confocal scanning
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/063—Radiation therapy using light comprising light transmitting means, e.g. optical fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/065—Light sources therefor
- A61N2005/0651—Diodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0661—Radiation therapy using light characterised by the wavelength of light used ultraviolet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0662—Visible light
Definitions
- the invention relates to localization and stimulation of nerve tissues, and more in particular to a method, apparatus and probe for optical nerve localization and optical nerve stimulation and treatment.
- nerves can be localized accurately prior to the intervention. For examples finding nerves may preserve or prevent resection during surgical procedures and allows for localized injection of pain relieving medicaments nearby nerves.
- localization procedures consist of localizing nerves in imaging modalities such as ultrasound or magnetic resonant imaging (MRI), whereby it may be sometimes difficult to find and identify tissue as being nerves.
- imaging modalities such as ultrasound or magnetic resonant imaging (MRI)
- the gold standard for confirmation of this presence is stimulation of the nerves by using an electrical stimulation.
- US 5,284,154 describes a method and apparatus for locating and identifying the function of specific peripheral nerves.
- the apparatus of US 5,284,154 includes a stimulus delivery means and a response-detecting means. Electrical stimulation is used for example to locate, identify the function of, and guard against the inadvertent cutting of specific nerves during surgical procedures.
- Electrical stimulation has several disadvantages, for example it may induce electrical burns on patients, which if unseen by surgeons can result in perforated organs and can also lead to peritonitis.
- the invention preferably seeks to mitigate, alleviate or eliminate one or more of the above mentioned disadvantages singly or in any combination.
- Nervous tissue is intended as the main component of the nervous system, e.g. in the brain, spinal cord, and nerves which regulate and control body functions.
- an optical probe assembly that comprises a housing comprising: one or more optical guides for guiding electromagnetic (EM) radiation towards a region of interest (ROI) and/or for detecting EM radiation scattered or emitted from the ROI.
- EM electromagnetic
- ROI region of interest
- the housing is or further comprises one or more fluid transport means for delivering a fluid towards the ROI.
- the optical probe assembly may be a disposable probe for use in an endoscope or more generally for uses related to laparoscopic surgery. It should be mentioned that the optical probe assembly according to the present invention is particularly suited for relative simple and large scale manufacturing which may in turn lower the unit-price per probe assembly. This is advantageous as the probe assembly due to sanitary requirements may be disposed after single use.
- the housing may be a flexible hollow tube.
- the tip of the housing towards the ROI may have a needle shape form.
- the housing is a needle, e.g. a photonic needle.
- optical guide may include, and is not limited to, optical fibers (multi-mode and single- mode), thin film optical paths, photonic crystal fibers, photonic band-gap fibers (PBG), polarization maintaining fibers, and the like.
- the optical probe assembly may also comprise more than one fiber i.e. a plurality of fibers or a fiber bundle.
- the fluid transport means may be channels, e.g. micro-channels ⁇ channels) allowing for fluid transport from an external fluid reservoir to the region of interest.
- the fluid is allowed to flow through the transporting means towards the region of interest to deliver fluid contained in an external fluid reservoir.
- the ROI comprises nervous tissue. This is generally when the optical probe assembly is used in combination with an apparatus for minimally invasive surgery.
- the fluid transported through the fluid transport means may comprise light absorbing materials.
- light absorbing materials may be chromophores, liposomes, shells, nanoparticles and coated nanoparticles that contain absorbing dye molecules.
- the fluid may comprise nerve blocks.
- Nerve blocks are herein defined as compositions for regional nerve blockade such as local anesthetic for injection onto or near nerve tissue, for example for pain control.
- nerve block may be lidocaine, epinephrine, steroid, and/or opioids.
- the one or more optical guides for guiding EM radiations comprises: at least one optical guide for guiding EM radiations towards the ROI; at least one optical guide for detecting EM radiations scattered or emitted from the ROI.
- the illumination and the detection of EM radiations is carried out by separate optical fibers, i.e. one or more optical fibers guides the EM radiations towards a ROI and some other one or more optical fibers detects EM radiations scattered or emitted from said ROI.
- spectroscopic localization of a nervous tissue is possible, as by illuminating through at least one optical guide for guiding EM radiations the nervous tissue, the light scattered or emitted from the area around the nervous tissue can be detected by the at least one optical guide for detecting EM radiations.
- In vivo spectroscopic analysis of the tissues allows for identification of the nervous tissue. This can be done for example by using a single optical channel monitoring a single wavelength or a narrow range of wavelengths and/or by using multiple optical channels monitoring a single wavelength or narrow ranges of wavelengths simultaneously.
- the EM radiations are within the UV7 Vis (Ultraviolet/Visible), NIR (Near-infrared) wavelength range.
- This use of EM radiations may be used for the illumination of the area of interest or for detection purposes so as to identify the areas where fluid may be delivered and/or for localizing the nervous tissue through optical spectroscopy.
- the EM radiations are light amplified by stimulated emission of radiation (LASER) beams.
- LASER stimulated emission of radiation
- the EM radiations are narrow band light emitting diode (LED) beams.
- the LASER radiation or a LED beam induces the optical stimulation of the nerve tissue.
- Absorption of the LASER beam may cause photochemical, photomechanical effects causing stimulation of the nervous tissue.
- Stimulation may occur through irradiation with a LASER beam having a wavelength range which is at least partially absorbed by the light absorbing materials contained in the fluid delivered in the area of the nerve tissue.
- the light absorbing materials absorb EM radiations within the wavelength range of said LASER beam.
- the LASER beam when light absorbing materials are present, may have a minimal absorption on the nervous tissue, maximum absorption in the light absorbing material and not significant absorption from other tissues around the nervous tissue.
- the LASER beam stimulation and light absorption can be tuned so as to match minimizing absorption of the beam from the nervous tissues. In this way collateral damage of the nervous tissues, such as thermal damage are minimized if not completely avoided.
- one important feature of the invention is that irradiation with LASER beam of the light absorbing materials causes in turn stimulation of the nerve tissue.
- a further advantage of the single apparatus and probe assembly of the invention is that the LASER beam guided through the probe assembly towards the region of interest may be used also for ablation surgery operation.
- the presence of an optical guide for guiding LASER beam towards the ROI in the probe assembly allows for detection and/or for further use of the LASER beam. In this way localization of nervous tissue, treatment and ablation in the area of interest can be conducted through the same single apparatus and probe assembly.
- the one or more optical guides for guiding EM radiations comprises at least one optical guide for guiding EM radiations in the UV/ Vis, NIR wavelength range towards the ROI and for guiding a LASER beam towards the ROI.
- the one or more optical guides for guiding EM radiations comprises at least one optical guide for guiding EM radiations in the UV/ Vis, NIR wavelength range towards the ROI and for guiding a LED beam towards the ROI.
- the illumination of the ROI for localization purposes and stimulation of the nerve tissue may be carried out by a single optical guide.
- a single optical guide may guide the EM radiations for illumination of the nerve tissue.
- the same optical guide may also guide more powerful EM radiations, such as a LASER beam and therefore provide the mean for stimulating the nerve tissue directly or through previous interaction with the light adsorbing materials.
- detection of the light scattered and/or emitted from the ROI may or may not be collected by the same optical guide.
- the one or more optical guides for guiding EM radiations comprises at least one optical guide for guiding EM radiations in the UV/ Vis, NIR wavelength range towards said ROI, and at least one optical guide for guiding LASER beam towards said ROI.
- the one or more optical guides for guiding EM radiations comprises at least one optical guide for guiding EM radiations in the UV/ Vis, NIR wavelength range towards said ROI, and at least one optical guide for guiding LED beam towards said ROI.
- Stimulation by LASER and illumination may be achieved by irradiation from at least two different optical guides.
- At least one optical guide provides illumination of the region of interest by guiding EM radiations in the UV/ Vis, NIR wavelength range.
- At least another optical guide provides optical stimulation of the region of interest by guiding a LASER beam towards the nerve tissue.
- illumination of the region of interest may be carried out by several optical guides such as optical fibers guiding EM radiations within the same wavelength range.
- the illumination of the ROI may be carried out by several optical guides such as optical fibers guiding EM radiations in different wavelength ranges. For example, it may be so that specific wavelength or wavelength ranges of interest for optical spectroscopy monitoring of the ROI may be provided by separate optical guides.
- the stimulation of the ROI may be carried out by more optical guides guiding LASER beam within the same or with different wavelength or narrow wavelengths range.
- the optical probe assembly according to first aspect further comprises at its distal end one or more lens systems.
- an apparatus for in vivo optical localization of a region of interest comprises: an optical probe assembly; at least one fist radiation source for generating an EM radiations beam, the at least one first radiation source optically coupled to the optical probe assembly, the probe being arranged to guide the radiation beam from said the radiation source towards said ROI, thereby providing illumination of the ROI; at least one second radiation source for generating an EM radiations beam, the at least one second radiation source optically coupled to the optical probe assembly, the probe being arranged to guide the radiation beam from the second radiation source towards the ROI, thereby providing stimulation of the ROI; at least one detector optically coupled to the optical probe assembly, the detector being arranged for detecting the ROI through the analysis of scattered or emitted radiation from the stimulated ROI.
- the at least one second radiation source optically coupled to the optical probe assembly provides illumination and/or stimulation of the ROI.
- the at least one second radiation source is a source for generating light amplified by stimulated emission of radiation (LASER) beams.
- LASER stimulated emission of radiation
- LASER sources examples include sources capable of generating a beam having either a fixed wavelength or tunable wavelength: pulsed infrared LASER, ruby LASER, Alexandrite LASER, solid state LASER, C0 2 LASER, N 2 LASER, excimer LASER, tunable optical parametric oscillator (OPO) LASER system, Holmium- doped:Yttrium Aluminum Garnet (Ho:YAG) LASER, or an Erbium doped: Yttrium
- the at least one second radiation source is a narrow band light emitting diode (LED).
- LED narrow band light emitting diode
- radiation sources for illumination are radiation sources used for optical spectroscopy such as continuum sources producing a broad range of wavelength, e.g. D 2 lamp, Hg lamp, Xe lamp, W lamp, Nerst Glower, Ni/Ch wire and globar (SiC) or line sources producing few discrete wavelengths, e.g. hollow cathode lamps, LED.
- LASER or EM radiations sources for illumination are coupled, e.g. thorough optical fibers, to the optical probe assembly.
- the apparatus further comprises an optical coupler, such as a beam splitter, so that illumination and stimulation can be alternated by alternatively selecting the source of radiation to be guided in the optical guide towards the nerve tissue.
- an optical coupler such as a beam splitter
- the detector may be any light detector, such as photo -transducers used for spectroscopic analysis in the UV/Vis and NIR spectral region, e.g. photodiodes arrays, photomultiplier, phototubes, thermal detectors, charge-coupled device (CCD) or
- CMOS complementary metal-oxide-semiconductor
- the at least one detector is a spectrophotometer.
- the apparatus according to the second aspect of the invention further comprises one or more fluid transport means for delivering a fluid towards the ROI.
- Fluid transport means may be connecting means such as tubing.
- the apparatus according to the second aspect of the invention further comprises a fluidic control unit for dispensing fluid towards the ROI, the fluidic control unit coupled to the optical probe assembly.
- the fluidic control unit may be coupled through connecting means, for example tubing, with the fluid transport means, such as for delivering a fluid towards the ROI.
- the fluidic control unit for dispensing the fluid may comprise at least one fluid reservoir.
- the fluidic control unit may dispense more than one fluid.
- dispensing of fluids comprising light absorbing materials may precede or follow dispensation of fluids comprising nerve blocks.
- Simultaneous delivery of fluids may be also envisaged through the action of the fluidic control unit.
- the apparatus according to the second aspect of the invention further comprises an electronic processing unit, a memory unit and a display unit operatively coupled with each other and with the probe assembly, radiation sources and/or with the fluidic control unit for controlling the apparatus functions.
- the apparatus according to the second aspect of the invention comprises a probe assembly according to the first aspect of the invention.
- a method for in vivo optical localization of nervous tissue comprises: localizing a nervous tissue by means of optical spectroscopy; optically stimulating said nervous tissue by exposing said nervous tissue to a LASER beam or a narrow band light emitting diode (LED) beam; detecting the presence of the stimulated nervous tissue by spectroscopic analysis of EM radiations emitted or scattered by the area of the stimulated nervous tissue.
- a LASER beam or a narrow band light emitting diode (LED) beam detecting the presence of the stimulated nervous tissue by spectroscopic analysis of EM radiations emitted or scattered by the area of the stimulated nervous tissue.
- optically stimulating the nervous tissue comprises providing light absorbing materials at the nervous tissue before exposing the nervous tissue to a LASER beam or a narrow band light emitting diode (LED) beam.
- LASER beam or a narrow band light emitting diode (LED) beam.
- LED narrow band light emitting diode
- light absorbing materials absorb EM radiations within the wavelength range of the LASER beam, i.e. the LASER beam used for stimulation or within the wavelength range of the narrow band light emitting diode (LED) beam.
- optically stimulating said nervous tissue comprises providing laser light to perform treatment to said nervous tissue.
- the detection of the presence of the stimulated nervous tissue comprises the detection of stimulated nerves through temperature sensitive spectral bands.
- the absorption coefficient of water is sensitive to temperature. By determining the absorption of water from the light collected by the optical probe assembly, the temperature in front of the tip of the optical probe can be determined. Details can be found in J. Biomed. Opt. 15, 037015 and are included herein by reference.
- the basic idea is to locate and confirm the location of nerve tissues by stimulating and monitoring the response of the nerve tissues. Therefore the method comprises approaching of the probe assembly to the nerve tissue to firstly localize the area where the nerve tissue of interest is located. This approaching does not involve a physical contact between the probe assembly and the nerve tissue and may be carried out, for example, under image guidance.
- the method then comprises the illumination of the nerve tissue, for example by a broad band light or a LASER beam to which follow the detection of the diffuse reflectance, fluorescence or Raman spectrum of the nerve tissue.
- Confirmation of the localization of the nerve tissue may include the application of an algorithm to spectrally distinguish nerve tissue from surrounding tissue.
- the nerve tissue can be optically stimulated by exposing it to a LASER beam.
- the response to the optical stimulation may be detected optically by monitoring the temperature dependent absorption bands of the nerve tissue, e.g. water absorption or fat absorption. Generally these bands lay in the NIR spectral region.
- the temperature dependence of characteristic fundamental vibrational modes of water may be taken as indication of the stimulation of the target nervous tissue.
- At least one of the characteristic absorption peaks of water may be monitored so that its variations induced by a temperature difference before and after optical stimulation of the nervous tissue may be taken as indication of nerve tissue stimulation.
- other temperature sensitive absorption peaks may used to detect optical stimulation of nervous tissue.
- a LASER beam may also be used for optical spectroscopic detection of the nerve using Fluorescence or Raman spectroscopy.
- one LASER beam is used for e.g. excitation of Fluorescence usually in the UV or Vis wavelength range, or another LASER for excitation of Raman spectroscopy usually in the Vis to NIR wavelength range.
- the LASER beam for stimulation of nerves usually has a wavelength in the NIR 1800-1900 nm wavelength range.
- optically stimulating the nervous tissue comprises providing LASER light to perform treatment to the nervous tissue.
- the method for in vivo optical localization of nervous tissue may further comprise monitoring of the muscle activity resulting from nerve tissue stimulation. This has the advantage of further confirming the presence and location of nerve tissue. Monitoring of the optical stimulation has also the advantage of preventing damages to the nerve tissue as if undesired values of light scattering are detected, for example due to rapid and excessive increase of temperature of the region of interest, ceasing of the stimulation may rapidly occur.
- the method for in vivo optical localization of nervous tissue may further comprise monitoring of the optical stimulation and ceasing of stimulation if non-nervous tissues are detected and/or if values associated to potential harm of the nervous tissue are encountered during the monitoring.
- light scattering and reflectance are commonly used to indicate light beams detected by the detector in response to light illumination or LASER illumination of the region of interest.
- a further advantage of the method is that in-situ, in vivo, LASER treatment may follow nerve location without the need of inserting further apparatus.
- a further advantage of the method is that by using focused LASER light the nerve stimulation can be performed with higher spatial resolution compared to the electrical stimulation, which might be preferable for selective stimulation of different types of nerves, e.g. sensory and motor nerves or even specific fascicles in a nerve bundle and to prevent damage to other tissue outside of the nerve.
- nerves e.g. sensory and motor nerves or even specific fascicles in a nerve bundle and to prevent damage to other tissue outside of the nerve.
- the optical probe assembly may be used for nervous tissue localization, for LASER ablation in situ.
- the LASER used for localization may be employed.
- a second LASER source may be couple to the optical probe assembly, e.g. an Infra-Red (IR) LASER.
- IR Infra-Red
- the method for in vivo optical localization of nervous tissue may further comprise LASER treating the area of interest, i.e. the area around the nerve tissue, by using the optical probe assembly and/or the apparatus according to the first and second aspect of the invention, respectively.
- the optical probe assembly according to the first aspect of the invention may further comprise at least an optical guide for guiding LASER beam towards the nervous tissue, thereby providing ablation of at least part of the nervous tissue and/or of the tissues in the area around the nervous tissue of interest.
- a separate optical guide dedicated to the guiding of a LASER beam to provide ablation may be needed if the LASER used for ablation has different characteristics than the LASER used for stimulation, e.g. an IR LASER has a sharp band in the infrared spectral region, e.g. between 1.8 and 2.3 micrometer, and therefore this LASER may require specific infrared-transmitting fibers as optical guides.
- a nerve tissue Following the localization of a nerve tissue, it may be so that treatment of the localized nerve tissue is needed, for example exposure to composition which may affect it function such as nerve blocks or other chemicals which may interact with the nervous tissue.
- the method for in vivo optical localization of nervous tissue may further comprise providing fluids comprising chemicals which interact with the nervous tissue before or after exposing the nervous tissue to a LASER beam.
- One of the advantages of the invention is that a single probe and/or a single apparatus can be used to monitor a nerve response during and after the optical stimulus.
- a single probe and/or a single apparatus to monitor a nerve response during and after the optical stimulus is done in conjunction with other neural activity responses detection, i.e. muscle movement, pain indicator and/or electrical response.
- one or multiple electrically conductive fibers may be embedded in the probe assembly. If one electrically conductive fiber is used, a grounding pad is in contact with the patient at a location away from the needle location. If multiple electrically conductive fibers are used, the grounding pad may be optional.
- the electrically conductive fibers may be used as an alternative to either electrically stimulate the nerve tissue and/or to record the nerve stimulation response alone or in combination with the optical fibers embedded in the probe assembly.
- the basic idea of the invention is to combine in a single probe and a single apparatus the ability of localizing nervous tissue and confirming this localization by optical stimulation of the localized nervous tissue. This stimulation is detected by monitoring the variations based on thermal sensitive spectroscopic features of light scattering from the area of the stimulated nervous tissue.
- Stimulation leading to a positive or negative nerve response is detected and discriminated by monitoring the spectroscopic features of light scattering from the area of the stimulated nervous tissue.
- Figure 1 is a schematic cross-sectional drawing of an optical probe assembly according to the present invention.
- Figure 2 is a schematic cross-sectional drawing of an optical probe assembly according to possible embodiments of the present invention.
- Figure 3 is a schematic cross-sectional drawing of an optical probe assembly according to other possible embodiments of the present invention.
- Figure 4 is a schematic cross-sectional drawing of an optical probe assembly according to other possible embodiments of the present invention where the optical guide for guiding a LASER beam comprises a focusing lens system.
- Figure 5 is a schematic drawing of an apparatus for in vivo optical localization of nervous tissue according to the present invention.
- Figure 6 is a schematic drawing of an apparatus for in vivo optical localization of nervous tissue according to embodiments of the present invention.
- Figure 7 is a flow chart for a method according to the invention.
- Figure 8 is a log plot of the absorption spectra of blood, water and fat.
- Figure 1 shows the cross section of an optical probe assembly 1 comprising a housing 2 confining a 3 as fluid transport means and a fiber optic 4, as optical guide for guiding EM radiations towards a nerve tissue while the probe assembly is located in the vicinity of a nerve tissue.
- Figure 2 shows the cross section of an optical probe assembly 5 comprising a housing 6 confining a 7 as fluid transport means and two optical fibers 8 and 9.
- Optical fiber 8 guides EM radiations towards a nerve tissue while optical guide 9 detects the EM radiations scattered or emitted from the area of the nerve tissue.
- Figure 3 shows the cross section of an optical probe assembly 10 comprising a housing 11 comprising fiber optics and for fluid transport.
- Fiber optic 12 guides EM radiations towards the nerve tissue, while fiber optic 13 detects EM radiations scattered from the nerve tissue area.
- housing 11 ay be used to transport the same fluid or different fluids towards the 14 and 15 in this embodiment are located at the periphery of optical guide 16 for guiding LASER beam towards the nerve tissue for stimulation purposes.
- any other geometry combining fiber optic embedded in the housing may be envisaged. For example it may be so that ber optics surround each other, such as an inner fiber optic is surrounded by an outer sharing the same geometric axis.
- Figures 1-3 do not show the tip of the probe assembly.
- An example of a tip 17 for the probe assembly 10 is shown in figure 4.
- the housing 11 has a tip 17 having the shape of a needle.
- Figure 4 shows flat end faced optical guide 19 for illumination of the nervous tissue and flat end faced optical guide 20 for detection of light scattered from the nerve tissue.
- Figure 5 shows also 21 and 22 for fluid transport and optical guide 23 for guiding LASER beam towards the nerve tissue.
- optical guide 23 has at its distal or sampling end part towards the ROI a lens system 24. This is advantageous so as to focus the LASER beam in a specific spot on the nerve tissue.
- the optical probe assembly comprises at least one optical guide for guiding a LASER beam, having a lens system at its distal end part, thereby focusing the LASER beam towards the ROI.
- FIG. 5 is a schematic drawing of an apparatus for in vivo optical localization of nervous tissue according to the present invention.
- the apparatus 27 comprises an optical probe assembly 25 optically connected through an optical guide 26, e.g. one or more optical fibers, to a device 30 for measuring light intensity, i.e. a device that can measure light intensity as a function of its wavelength, e.g. a spectrophotometer.
- Device 30 comprises a source of EM radiations in the UV/Vis or NIR region 31 and a detector 32 for detecting the light.
- Optical probe assembly 25 is also optically connected through optical guide 34 to a LASER source 33.
- a fluidic control unit 29 connected via, e.g. tubing 28, to optical probe assembly 25 may control the release and delivery of desired fluids towards the nervous tissue.
- Fluidic control unit 29, LASER source 33 and spectrophotometer 30 may all be connected to an electronic processing unit 35 for controlling the apparatus functions.
- the fluidic control unit 29 is also connected to a reservoir of fluids (not shown).
- the apparatus 37 comprises an optical probe assembly 25 which is connected via a single optical fiber to an optical coupler/beam splitter 38.
- the beam splitter 38 is connected to the EM source of light 31 of spectrophotometer 30 and to the LASER source 33 so that illumination from the LASER source and from the EM source of light can be alternated selectively.
- Figure 7 is a flow chart for a method according to the invention.
- the method comprise: localizing a nervous tissue by means of optical spectroscopy (SI); optically stimulating the nervous tissue by exposing said nervous tissue to a LASER beam (S2);
- SI optical spectroscopy
- S2 LASER beam
- the probe assembly may contain a system for acquiring images, in 2 or 3 dimensions, of nerve tissue microstructure, e.g. by means of confocal detection through a optical fiber scanning microscope.
- the at least one optical guide is used to guide LASER beam for nervous tissue stimulation and to illuminate the tissue for images acquisition.
- Automated image segmentation algorithms may be used to detect nerve tissue from the images. The output of these algorithms may be used to direct LASER beam stimulation towards a precise location.
- the housing may be used as a fluid transport means for delivering a fluid towards the ROI.
- the housing of the optical probe assembly may be a hollow tube and a stylet, e.g. mandrin may be located inside the hollow tube filling up the entire volume of the hollow tube.
- the stylet may contain the one or more optical guides according to the invention.
- the assembly probe may be brought close to a nerve tissue to stimulate it so as to confirm that indeed the location is correct.
- the stylet may be removed while keeping the hollow tube at its location.
- a pumping means such a syringe
- a fluid comprising, e.g. steroid or the like, is allowed to flow towards the nerve tissue of interest via the housing, i.e. the hollow tube.
- the fluid transport means may be the housing in itself after removing at least part of the probe assembly.
- Figure 8 is a log plot of the absorption spectra of blood, water and fat.
- confirmation of the localization of the nerve tissue may include the application of an algorithm to spectrally distinguish nerve tissue from surrounding tissue.
- This algorithm has been developed that can be used to derive optical tissue properties such as the scattering coefficient and absorption coefficient of different tissue chromophores: e.g. hemoglobin, oxygenated hemoglobin, water, fat etc. These properties are different between different tissue types, such as subcutaneous fat, muscle and nervous tissue.
- the spectral fitting may be performed by making use of the analytically derived formula for reflectance spectroscopy e.g. from T.J. Farrel et alter, Med. Phys. 19 (1992) p879-888 or R. Nachabe, et alter, J. Biomed. Opt. 15, 037015 (2010).
- the three macroscopic parameters describing the probability of interaction with tissue are: the absorption coefficient ⁇ ⁇ and the scattering coefficient ⁇ 8 both in cm "1 as well as by g which is the mean cosine of the scattering angle. Furthermore, we have the total reduced attenuation coefficient ⁇ that gives the total chance for interaction with tissue
- the albedo a' is the probability of scattering relative to the total probability of interaction
- the main absorbing constituents in normal tissue dominating the absorption in the visible and near-infrared range are blood (i.e. hemoglobin), water and fat.
- blood i.e. hemoglobin
- water and fat the absorption coefficient of these chromophores as a function of the wavelength are presented. Note that blood dominates the absorption in the visible range, while water and fat dominate in the near infrared range.
- the probe assembly may contain a phase-sensitive reflectometry system with interferometric detection to optically monitor the expansions of axons or dendrites resulting from LASER beam stimulation.
- the total absorption coefficient is a linear combination of the absorption coefficients of for instance blood, water and fat (hence for each component the value of that shown in figure 8 multiplied by its volume fraction).
- Another way to discriminate differences in spectra is by making use of a principal components analysis. This method allows classification of differences in spectra and thus allows discrimination between tissues. How to extract the intrinsic fluorescence from the measured fluorescence can be found for instance in Zhang et al., Optics Letters 25 (2000) p.1451.
- optical stimulation is performed by means of stimulating light-sensitive ionic channels like for example Channelrhodopsin-2, a light- sensitive cation channel that can be used to photo-stimulate mammalian neurons, e.g. see Nat Neurosci. 2005 Sep;8(9): 1263-8.
Abstract
The invention relates to identification and stimulation of nerve tissues, and more in particular to a method, apparatus and probe for optical nerve localization and optical nerve stimulation. The invention combines in a single apparatus the localization and the verification of the presence of nerve tissue by optical stimulation. The stimulation is detected by monitoring the variations based on thermal sensitive spectroscopic features of light scattering from the area of the stimulated nervous tissue.
Description
Device for optical nerve localization and optical nerve stimulation
FIELD OF THE INVENTION
The invention relates to localization and stimulation of nerve tissues, and more in particular to a method, apparatus and probe for optical nerve localization and optical nerve stimulation and treatment.
BACKGROUND OF THE INVENTION
In various clinical interventions, it is important that nerves can be localized accurately prior to the intervention. For examples finding nerves may preserve or prevent resection during surgical procedures and allows for localized injection of pain relieving medicaments nearby nerves. Currently localization procedures consist of localizing nerves in imaging modalities such as ultrasound or magnetic resonant imaging (MRI), whereby it may be sometimes difficult to find and identify tissue as being nerves.
There is a clinical desire for confirmation of the presence of the nerve in order to prevent complications. The gold standard for confirmation of this presence is stimulation of the nerves by using an electrical stimulation.
US 5,284,154 describes a method and apparatus for locating and identifying the function of specific peripheral nerves. The apparatus of US 5,284,154 includes a stimulus delivery means and a response-detecting means. Electrical stimulation is used for example to locate, identify the function of, and guard against the inadvertent cutting of specific nerves during surgical procedures.
Electrical stimulation has several disadvantages, for example it may induce electrical burns on patients, which if unseen by surgeons can result in perforated organs and can also lead to peritonitis.
Recently, stimulation of nerves using optical energy has got increased intention in the literature. However, no practical device is known for in- vivo application.
The inventor of the present invention has appreciated that an improved apparatus and method for nerve localization and detection is of benefit, and has in consequence devised the present invention.
SUMMARY OF THE INVENTION
It would be advantageous to achieve an improved in vivo nerve localization and detection so as to identify nerve tissues from the surrounding tissues without physically interacting with the nerve tissues. Physically interacting is herein defined as when the probe surface is in contact with the surface of the nerve tissue, e.g. when probe and nerve tissue touch each other.
It would also be advantageous to limit the number of different devices used for in vivo localization and treatment of nervous tissues in minimally invasive surgery.
In general, the invention preferably seeks to mitigate, alleviate or eliminate one or more of the above mentioned disadvantages singly or in any combination. In particular, it may be seen as an object of the present invention to provide a method that solves the above mentioned problems, or other problems, of the prior art.
For the purpose of this application the word "nerve" is referred herein also as "nervous", e.g. nerve tissue and nervous tissue are used as synonymous. Nervous tissue is intended as the main component of the nervous system, e.g. in the brain, spinal cord, and nerves which regulate and control body functions.
To better address one or more of these concerns, in a first aspect of the invention an optical probe assembly is presented that comprises a housing comprising: one or more optical guides for guiding electromagnetic (EM) radiation towards a region of interest (ROI) and/or for detecting EM radiation scattered or emitted from the ROI.
In some embodiments the housing is or further comprises one or more fluid transport means for delivering a fluid towards the ROI.
The optical probe assembly may be a disposable probe for use in an endoscope or more generally for uses related to laparoscopic surgery. It should be mentioned that the optical probe assembly according to the present invention is particularly suited for relative simple and large scale manufacturing which may in turn lower the unit-price per probe assembly. This is advantageous as the probe assembly due to sanitary requirements may be disposed after single use.
The housing may be a flexible hollow tube. In some embodiments the tip of the housing towards the ROI may have a needle shape form. In some other embodiments the housing is a needle, e.g. a photonic needle.
In the context of the present invention it is to be understood that the term "optical guide" may include, and is not limited to, optical fibers (multi-mode and single- mode), thin film optical paths, photonic crystal fibers, photonic band-gap fibers (PBG),
polarization maintaining fibers, and the like. The optical probe assembly may also comprise more than one fiber i.e. a plurality of fibers or a fiber bundle.
The fluid transport means may be channels, e.g. micro-channels ^channels) allowing for fluid transport from an external fluid reservoir to the region of interest.
The fluid is allowed to flow through the transporting means towards the region of interest to deliver fluid contained in an external fluid reservoir.
In some embodiments the ROI comprises nervous tissue. This is generally when the optical probe assembly is used in combination with an apparatus for minimally invasive surgery.
In some embodiments the fluid transported through the fluid transport means may comprise light absorbing materials. An example of light absorbing materials may be chromophores, liposomes, shells, nanoparticles and coated nanoparticles that contain absorbing dye molecules.
In some other embodiments the fluid may comprise nerve blocks. Nerve blocks are herein defined as compositions for regional nerve blockade such as local anesthetic for injection onto or near nerve tissue, for example for pain control.
Examples of nerve block may be lidocaine, epinephrine, steroid, and/or opioids.
In some embodiments according to the first aspect the one or more optical guides for guiding EM radiations comprises: at least one optical guide for guiding EM radiations towards the ROI; at least one optical guide for detecting EM radiations scattered or emitted from the ROI.
In some embodiments the illumination and the detection of EM radiations is carried out by separate optical fibers, i.e. one or more optical fibers guides the EM radiations towards a ROI and some other one or more optical fibers detects EM radiations scattered or emitted from said ROI.
In this way, spectroscopic localization of a nervous tissue is possible, as by illuminating through at least one optical guide for guiding EM radiations the nervous tissue, the light scattered or emitted from the area around the nervous tissue can be detected by the at least one optical guide for detecting EM radiations. In vivo spectroscopic analysis of the tissues allows for identification of the nervous tissue. This can be done for example by using a single optical channel monitoring a single wavelength or a narrow range of wavelengths and/or by using multiple optical channels monitoring a single wavelength or narrow ranges of wavelengths simultaneously.
In some embodiments according to the first aspect of the invention the EM radiations are within the UV7 Vis (Ultraviolet/Visible), NIR (Near-infrared) wavelength range.
This use of EM radiations, e.g. within the Vis wavelength range, may be used for the illumination of the area of interest or for detection purposes so as to identify the areas where fluid may be delivered and/or for localizing the nervous tissue through optical spectroscopy.
In some embodiments according to the first aspect of the invention the EM radiations are light amplified by stimulated emission of radiation (LASER) beams.
In some embodiments according to the first aspect of the invention the EM radiations are narrow band light emitting diode (LED) beams.
The LASER radiation or a LED beam induces the optical stimulation of the nerve tissue. Absorption of the LASER beam may cause photochemical, photomechanical effects causing stimulation of the nervous tissue. Stimulation may occur through irradiation with a LASER beam having a wavelength range which is at least partially absorbed by the light absorbing materials contained in the fluid delivered in the area of the nerve tissue.
Indeed, in some embodiments the light absorbing materials absorb EM radiations within the wavelength range of said LASER beam. Advantageously the LASER beam, when light absorbing materials are present, may have a minimal absorption on the nervous tissue, maximum absorption in the light absorbing material and not significant absorption from other tissues around the nervous tissue. Indeed, the LASER beam stimulation and light absorption can be tuned so as to match minimizing absorption of the beam from the nervous tissues. In this way collateral damage of the nervous tissues, such as thermal damage are minimized if not completely avoided. In general independently from the mechanism causing transfer of energy between the light absorbing materials and the nerve tissue causing its stimulation, one important feature of the invention is that irradiation with LASER beam of the light absorbing materials causes in turn stimulation of the nerve tissue.
A further advantage of the single apparatus and probe assembly of the invention is that the LASER beam guided through the probe assembly towards the region of interest may be used also for ablation surgery operation. The presence of an optical guide for guiding LASER beam towards the ROI in the probe assembly allows for detection and/or for further use of the LASER beam. In this way localization of nervous tissue, treatment and ablation in the area of interest can be conducted through the same single apparatus and probe assembly.
In some embodiments according to the first aspect of the invention the one or more optical guides for guiding EM radiations comprises at least one optical guide for guiding EM radiations in the UV/ Vis, NIR wavelength range towards the ROI and for guiding a LASER beam towards the ROI.
In some embodiments according to the first aspect of the invention the one or more optical guides for guiding EM radiations comprises at least one optical guide for guiding EM radiations in the UV/ Vis, NIR wavelength range towards the ROI and for guiding a LED beam towards the ROI.
In some embodiments the illumination of the ROI for localization purposes and stimulation of the nerve tissue may be carried out by a single optical guide.
A single optical guide may guide the EM radiations for illumination of the nerve tissue. The same optical guide may also guide more powerful EM radiations, such as a LASER beam and therefore provide the mean for stimulating the nerve tissue directly or through previous interaction with the light adsorbing materials. In these embodiments detection of the light scattered and/or emitted from the ROI may or may not be collected by the same optical guide.
In some other embodiments according to the first aspect of the invention the one or more optical guides for guiding EM radiations comprises at least one optical guide for guiding EM radiations in the UV/ Vis, NIR wavelength range towards said ROI, and at least one optical guide for guiding LASER beam towards said ROI.
In some other embodiments according to the first aspect of the invention the one or more optical guides for guiding EM radiations comprises at least one optical guide for guiding EM radiations in the UV/ Vis, NIR wavelength range towards said ROI, and at least one optical guide for guiding LED beam towards said ROI.
Stimulation by LASER and illumination may be achieved by irradiation from at least two different optical guides. At least one optical guide provides illumination of the region of interest by guiding EM radiations in the UV/ Vis, NIR wavelength range. At least another optical guide provides optical stimulation of the region of interest by guiding a LASER beam towards the nerve tissue.
In some embodiments illumination of the region of interest may be carried out by several optical guides such as optical fibers guiding EM radiations within the same wavelength range. In some other embodiments the illumination of the ROI may be carried out by several optical guides such as optical fibers guiding EM radiations in different wavelength ranges. For example, it may be so that specific wavelength or wavelength ranges
of interest for optical spectroscopy monitoring of the ROI may be provided by separate optical guides.
In some other embodiments the stimulation of the ROI may be carried out by more optical guides guiding LASER beam within the same or with different wavelength or narrow wavelengths range.
In some embodiments the optical probe assembly according to first aspect further comprises at its distal end one or more lens systems.
To better address one or more of previous cited concerns, in a second aspect of the invention an apparatus for in vivo optical localization of a region of interest (ROI), is presented that comprises: an optical probe assembly; at least one fist radiation source for generating an EM radiations beam, the at least one first radiation source optically coupled to the optical probe assembly, the probe being arranged to guide the radiation beam from said the radiation source towards said ROI, thereby providing illumination of the ROI; at least one second radiation source for generating an EM radiations beam, the at least one second radiation source optically coupled to the optical probe assembly, the probe being arranged to guide the radiation beam from the second radiation source towards the ROI, thereby providing stimulation of the ROI; at least one detector optically coupled to the optical probe assembly, the detector being arranged for detecting the ROI through the analysis of scattered or emitted radiation from the stimulated ROI.
In some embodiments according to the second aspect of the invention the at least one second radiation source optically coupled to the optical probe assembly, provides illumination and/or stimulation of the ROI.
In some embodiments according to the second aspect of the invention the at least one second radiation source is a source for generating light amplified by stimulated emission of radiation (LASER) beams.
Examples of LASER sources that may be used are sources capable of generating a beam having either a fixed wavelength or tunable wavelength: pulsed infrared LASER, ruby LASER, Alexandrite LASER, solid state LASER, C02 LASER, N2 LASER, excimer LASER, tunable optical parametric oscillator (OPO) LASER system, Holmium- doped:Yttrium Aluminum Garnet (Ho:YAG) LASER, or an Erbium doped: Yttrium
Aluminum Garnet (Er:YAG) LASER.
In some embodiments according to the second aspect of the invention the at least one second radiation source is a narrow band light emitting diode (LED).
Examples of radiation sources for illumination are radiation sources used for optical spectroscopy such as continuum sources producing a broad range of wavelength, e.g. D2 lamp, Hg lamp, Xe lamp, W lamp, Nerst Glower, Ni/Ch wire and globar (SiC) or line sources producing few discrete wavelengths, e.g. hollow cathode lamps, LED.
LASER or EM radiations sources for illumination are coupled, e.g. thorough optical fibers, to the optical probe assembly.
In those embodiments, where a single optical guide guides both LASER beam and UV/Vis/NIR radiations for illumination purposes, the apparatus further comprises an optical coupler, such as a beam splitter, so that illumination and stimulation can be alternated by alternatively selecting the source of radiation to be guided in the optical guide towards the nerve tissue.
The detector may be any light detector, such as photo -transducers used for spectroscopic analysis in the UV/Vis and NIR spectral region, e.g. photodiodes arrays, photomultiplier, phototubes, thermal detectors, charge-coupled device (CCD) or
complementary metal-oxide-semiconductor (CMOS).
In some embodiments the at least one detector is a spectrophotometer.
In some embodiments the apparatus according to the second aspect of the invention further comprises one or more fluid transport means for delivering a fluid towards the ROI.
Fluid transport means may be connecting means such as tubing.
In further embodiments the apparatus according to the second aspect of the invention further comprises a fluidic control unit for dispensing fluid towards the ROI, the fluidic control unit coupled to the optical probe assembly.
The fluidic control unit may be coupled through connecting means, for example tubing, with the fluid transport means, such as
for delivering a fluid towards the ROI.
In further embodiments the fluidic control unit for dispensing the fluid may comprise at least one fluid reservoir.
In some embodiments the fluidic control unit may dispense more than one fluid. For example dispensing of fluids comprising light absorbing materials may precede or follow dispensation of fluids comprising nerve blocks. Simultaneous delivery of fluids may be also envisaged through the action of the fluidic control unit.
In some further embodiments the apparatus according to the second aspect of the invention further comprises an electronic processing unit, a memory unit and a display
unit operatively coupled with each other and with the probe assembly, radiation sources and/or with the fluidic control unit for controlling the apparatus functions.
In some embodiments the apparatus according to the second aspect of the invention comprises a probe assembly according to the first aspect of the invention.
To better address one or more of previous cited concerns, in a third aspect of the invention a method for in vivo optical localization of nervous tissue is presented. The method comprises: localizing a nervous tissue by means of optical spectroscopy; optically stimulating said nervous tissue by exposing said nervous tissue to a LASER beam or a narrow band light emitting diode (LED) beam; detecting the presence of the stimulated nervous tissue by spectroscopic analysis of EM radiations emitted or scattered by the area of the stimulated nervous tissue.
In a further aspect of the invention a method for in-vivo optical localization of nervous tissue using a probe assembly according to the first aspect is presented.
In a further aspect of the invention a method for optical localization of nervous tissue using an apparatus according to the second aspect of the invention is presented.
In further embodiments according to the third aspect of the invention optically stimulating the nervous tissue comprises providing light absorbing materials at the nervous tissue before exposing the nervous tissue to a LASER beam or a narrow band light emitting diode (LED) beam.
In some embodiments according the third aspect of the invention light absorbing materials absorb EM radiations within the wavelength range of the LASER beam, i.e. the LASER beam used for stimulation or within the wavelength range of the narrow band light emitting diode (LED) beam.
In some other embodiments according the third aspect of the invention optically stimulating said nervous tissue comprises providing laser light to perform treatment to said nervous tissue.
In some embodiments the detection of the presence of the stimulated nervous tissue comprises the detection of stimulated nerves through temperature sensitive spectral bands.
Generally, the absorption coefficient of water is sensitive to temperature. By determining the absorption of water from the light collected by the optical probe assembly, the temperature in front of the tip of the optical probe can be determined. Details can be found in J. Biomed. Opt. 15, 037015 and are included herein by reference.
In the method of the invention the basic idea is to locate and confirm the location of nerve tissues by stimulating and monitoring the response of the nerve tissues. Therefore the method comprises approaching of the probe assembly to the nerve tissue to firstly localize the area where the nerve tissue of interest is located. This approaching does not involve a physical contact between the probe assembly and the nerve tissue and may be carried out, for example, under image guidance.
The method then comprises the illumination of the nerve tissue, for example by a broad band light or a LASER beam to which follow the detection of the diffuse reflectance, fluorescence or Raman spectrum of the nerve tissue. Confirmation of the localization of the nerve tissue may include the application of an algorithm to spectrally distinguish nerve tissue from surrounding tissue. Once localized the nerve tissue can be optically stimulated by exposing it to a LASER beam. The response to the optical stimulation may be detected optically by monitoring the temperature dependent absorption bands of the nerve tissue, e.g. water absorption or fat absorption. Generally these bands lay in the NIR spectral region. In particular, the temperature dependence of characteristic fundamental vibrational modes of water may be taken as indication of the stimulation of the target nervous tissue. For example, in a NIR spectrum at least one of the characteristic absorption peaks of water may be monitored so that its variations induced by a temperature difference before and after optical stimulation of the nervous tissue may be taken as indication of nerve tissue stimulation. In some embodiments other temperature sensitive absorption peaks may used to detect optical stimulation of nervous tissue.
In some embodiments a LASER beam may also be used for optical spectroscopic detection of the nerve using Fluorescence or Raman spectroscopy. In that one LASER beam is used for e.g. excitation of Fluorescence usually in the UV or Vis wavelength range, or another LASER for excitation of Raman spectroscopy usually in the Vis to NIR wavelength range. The LASER beam for stimulation of nerves usually has a wavelength in the NIR 1800-1900 nm wavelength range.
In some embodiments according to the third aspect of the invention optically stimulating the nervous tissue comprises providing LASER light to perform treatment to the nervous tissue.
The method for in vivo optical localization of nervous tissue according to the third aspect of the invention may further comprise monitoring of the muscle activity resulting from nerve tissue stimulation. This has the advantage of further confirming the presence and location of nerve tissue.
Monitoring of the optical stimulation has also the advantage of preventing damages to the nerve tissue as if undesired values of light scattering are detected, for example due to rapid and excessive increase of temperature of the region of interest, ceasing of the stimulation may rapidly occur.
Accordingly, the method for in vivo optical localization of nervous tissue according to the third aspect of the invention may further comprise monitoring of the optical stimulation and ceasing of stimulation if non-nervous tissues are detected and/or if values associated to potential harm of the nervous tissue are encountered during the monitoring.
For the purpose of the application light scattering and reflectance are commonly used to indicate light beams detected by the detector in response to light illumination or LASER illumination of the region of interest.
A further advantage of the method is that in-situ, in vivo, LASER treatment may follow nerve location without the need of inserting further apparatus.
A further advantage of the method is that by using focused LASER light the nerve stimulation can be performed with higher spatial resolution compared to the electrical stimulation, which might be preferable for selective stimulation of different types of nerves, e.g. sensory and motor nerves or even specific fascicles in a nerve bundle and to prevent damage to other tissue outside of the nerve.
Following the localization of a nerve tissue, it may be so that treatment of the localized nerve tissue is needed, e.g. ablation by laser treatment. It is therefore possible to use the optical probe assembly, already used for nervous tissue localization, for LASER ablation in situ. Depending on the LASER wavelength needed, the LASER used for localization may be employed. Alternatively a second LASER source may be couple to the optical probe assembly, e.g. an Infra-Red (IR) LASER.
Accordingly, the method for in vivo optical localization of nervous tissue may further comprise LASER treating the area of interest, i.e. the area around the nerve tissue, by using the optical probe assembly and/or the apparatus according to the first and second aspect of the invention, respectively.
Accordingly the optical probe assembly according to the first aspect of the invention may further comprise at least an optical guide for guiding LASER beam towards the nervous tissue, thereby providing ablation of at least part of the nervous tissue and/or of the tissues in the area around the nervous tissue of interest. A separate optical guide dedicated to the guiding of a LASER beam to provide ablation may be needed if the LASER used for ablation has different characteristics than the LASER used for stimulation, e.g. an IR LASER
has a sharp band in the infrared spectral region, e.g. between 1.8 and 2.3 micrometer, and therefore this LASER may require specific infrared-transmitting fibers as optical guides.
Following the localization of a nerve tissue, it may be so that treatment of the localized nerve tissue is needed, for example exposure to composition which may affect it function such as nerve blocks or other chemicals which may interact with the nervous tissue.
Accordingly the method for in vivo optical localization of nervous tissue according to the third aspect of the invention may further comprise providing fluids comprising chemicals which interact with the nervous tissue before or after exposing the nervous tissue to a LASER beam.
One of the advantages of the invention is that a single probe and/or a single apparatus can be used to monitor a nerve response during and after the optical stimulus.
In some other embodiments the use of a single probe and/or a single apparatus to monitor a nerve response during and after the optical stimulus is done in conjunction with other neural activity responses detection, i.e. muscle movement, pain indicator and/or electrical response.
In those embodiments in addition to optical guides and
one or multiple electrically conductive fibers may be embedded in the probe assembly. If one electrically conductive fiber is used, a grounding pad is in contact with the patient at a location away from the needle location. If multiple electrically conductive fibers are used, the grounding pad may be optional.
The electrically conductive fibers may be used as an alternative to either electrically stimulate the nerve tissue and/or to record the nerve stimulation response alone or in combination with the optical fibers embedded in the probe assembly.
The basic idea of the invention is to combine in a single probe and a single apparatus the ability of localizing nervous tissue and confirming this localization by optical stimulation of the localized nervous tissue. This stimulation is detected by monitoring the variations based on thermal sensitive spectroscopic features of light scattering from the area of the stimulated nervous tissue.
Stimulation leading to a positive or negative nerve response is detected and discriminated by monitoring the spectroscopic features of light scattering from the area of the stimulated nervous tissue.
In general the various aspects of the invention may be combined and coupled in any way possible within the scope of the invention. These and other aspects, features
and/or advantages of the invention will be apparent from and elucidated with reference to the embodiments described hereinafter.
BRIEF DESCRIPTION OF THE DRAWINGS
Embodiments of the invention will be described, by way of example only, with reference to the drawings, in which
Figure 1 is a schematic cross-sectional drawing of an optical probe assembly according to the present invention.
Figure 2 is a schematic cross-sectional drawing of an optical probe assembly according to possible embodiments of the present invention.
Figure 3 is a schematic cross-sectional drawing of an optical probe assembly according to other possible embodiments of the present invention.
Figure 4 is a schematic cross-sectional drawing of an optical probe assembly according to other possible embodiments of the present invention where the optical guide for guiding a LASER beam comprises a focusing lens system.
Figure 5 is a schematic drawing of an apparatus for in vivo optical localization of nervous tissue according to the present invention.
Figure 6 is a schematic drawing of an apparatus for in vivo optical localization of nervous tissue according to embodiments of the present invention.
Figure 7 is a flow chart for a method according to the invention.
Figure 8 is a log plot of the absorption spectra of blood, water and fat.
DESCRIPTION OF EMBODIMENTS
An embodiment of the invention is illustrated in figure 1. Figure 1 shows the cross section of an optical probe assembly 1 comprising a housing 2 confining a
3 as fluid transport means and a fiber optic 4, as optical guide for guiding EM radiations towards a nerve tissue while the probe assembly is located in the vicinity of a nerve tissue.
Figure 2 shows the cross section of an optical probe assembly 5 comprising a housing 6 confining a
7 as fluid transport means and two optical fibers 8 and 9. Optical fiber 8 guides EM radiations towards a nerve tissue while optical guide 9 detects the EM radiations scattered or emitted from the area of the nerve tissue.
Figure 3 shows the cross section of an optical probe assembly 10 comprising a housing 11 comprising fiber optics and for fluid transport. Fiber optic 12 guides EM radiations towards the nerve tissue, while fiber optic 13 detects EM radiations scattered
from the nerve tissue area. In housing 11, ay be used to transport the same fluid or different fluids towards the
14 and 15 in this embodiment are located at the periphery of optical guide 16 for guiding LASER beam towards the nerve tissue for stimulation purposes. However, any other geometry combining fiber optic embedded in the housing may be envisaged. For example it may be so that
ber optics surround each other, such as an inner fiber optic is surrounded by an outer
sharing the same geometric axis.
Figures 1-3 do not show the tip of the probe assembly. An example of a tip 17 for the probe assembly 10 is shown in figure 4. The housing 11 has a tip 17 having the shape of a needle. Figure 4 shows flat end faced optical guide 19 for illumination of the nervous tissue and flat end faced optical guide 20 for detection of light scattered from the nerve tissue. Figure 5 shows also
21 and 22 for fluid transport and optical guide 23 for guiding LASER beam towards the nerve tissue. In this embodiment optical guide 23 has at its distal or sampling end part towards the ROI a lens system 24. This is advantageous so as to focus the LASER beam in a specific spot on the nerve tissue. Indeed, in some embodiments the optical probe assembly comprises at least one optical guide for guiding a LASER beam, having a lens system at its distal end part, thereby focusing the LASER beam towards the ROI.
Figure 5 is a schematic drawing of an apparatus for in vivo optical localization of nervous tissue according to the present invention. The apparatus 27 comprises an optical probe assembly 25 optically connected through an optical guide 26, e.g. one or more optical fibers, to a device 30 for measuring light intensity, i.e. a device that can measure light intensity as a function of its wavelength, e.g. a spectrophotometer. Device 30 comprises a source of EM radiations in the UV/Vis or NIR region 31 and a detector 32 for detecting the light. Optical probe assembly 25 is also optically connected through optical guide 34 to a LASER source 33. A fluidic control unit 29 connected via, e.g. tubing 28, to optical probe assembly 25 may control the release and delivery of desired fluids towards the nervous tissue. Fluidic control unit 29, LASER source 33 and spectrophotometer 30 may all be connected to an electronic processing unit 35 for controlling the apparatus functions.
The fluidic control unit 29 is also connected to a reservoir of fluids (not shown).
In some embodiments as shown in figure 6, the apparatus 37 comprises an optical probe assembly 25 which is connected via a single optical fiber to an optical
coupler/beam splitter 38. The beam splitter 38 is connected to the EM source of light 31 of spectrophotometer 30 and to the LASER source 33 so that illumination from the LASER source and from the EM source of light can be alternated selectively.
Figure 7 is a flow chart for a method according to the invention. The method comprise: localizing a nervous tissue by means of optical spectroscopy (SI); optically stimulating the nervous tissue by exposing said nervous tissue to a LASER beam (S2);
detecting the presence of the stimulated nervous tissue by spectroscopic analysis of EM radiations emitted or scattered by the stimulated nervous tissue (S3).
In some embodiments the probe assembly may contain a system for acquiring images, in 2 or 3 dimensions, of nerve tissue microstructure, e.g. by means of confocal detection through a optical fiber scanning microscope. In these embodiments, the at least one optical guide is used to guide LASER beam for nervous tissue stimulation and to illuminate the tissue for images acquisition. Automated image segmentation algorithms may be used to detect nerve tissue from the images. The output of these algorithms may be used to direct LASER beam stimulation towards a precise location.
In some embodiments the housing may be used as a fluid transport means for delivering a fluid towards the ROI. For example, the housing of the optical probe assembly may be a hollow tube and a stylet, e.g. mandrin may be located inside the hollow tube filling up the entire volume of the hollow tube. The stylet may contain the one or more optical guides according to the invention. During the process for optical detection and stimulation of the nervous tissue, the assembly probe may be brought close to a nerve tissue to stimulate it so as to confirm that indeed the location is correct. At this stage the stylet may be removed while keeping the hollow tube at its location. By connecting a pumping means, such a syringe to the hollow tube, a fluid, comprising, e.g. steroid or the like, is allowed to flow towards the nerve tissue of interest via the housing, i.e. the hollow tube. In this way the fluid transport means may be the housing in itself after removing at least part of the probe assembly.
Figure 8 is a log plot of the absorption spectra of blood, water and fat.
In figure 8 the characteristic absorption peeks of Hemoglobin 42, Oxygenated Hemoglobin 43, Water 40 and Fat 41 may be observed.
Algorithm
As mentioned confirmation of the localization of the nerve tissue may include the application of an algorithm to spectrally distinguish nerve tissue from surrounding tissue.
This algorithm has been developed that can be used to derive optical tissue properties such as the scattering coefficient and absorption coefficient of different tissue chromophores: e.g. hemoglobin, oxygenated hemoglobin, water, fat etc. These properties are different between different tissue types, such as subcutaneous fat, muscle and nervous tissue.
In more detail the algorithm can be described as follows. The spectral fitting may be performed by making use of the analytically derived formula for reflectance spectroscopy e.g. from T.J. Farrel et alter, Med. Phys. 19 (1992) p879-888 or R. Nachabe, et alter, J. Biomed. Opt. 15, 037015 (2010).
This reflectance distribution R is given by (ρ) = { (ρ , ζ0)δ (ζ0 -1/ μ/)&(
In this formula the three macroscopic parameters describing the probability of interaction with tissue are: the absorption coefficient μα and the scattering coefficient μ8 both in cm"1 as well as by g which is the mean cosine of the scattering angle. Furthermore, we have the total reduced attenuation coefficient μ^ that gives the total chance for interaction with tissue
μ/= μβ + 1 - £) . ( 2 )
The albedo a' is the probability of scattering relative to the total probability of interaction
α'= μ8 / μ/ . ( 3 )
We assume a point source at a depth z0=l^t' and no boundary mismatch hence
Furthermore, we assume that the scattering coefficient can be written as μ (λ) = αλ" ( 4 )
The main absorbing constituents in normal tissue dominating the absorption in the visible and near-infrared range are blood (i.e. hemoglobin), water and fat. In figure 8 the absorption coefficient of these chromophores as a function of the wavelength are presented.
Note that blood dominates the absorption in the visible range, while water and fat dominate in the near infrared range.
In some other embodiments the probe assembly may contain a phase-sensitive reflectometry system with interferometric detection to optically monitor the expansions of axons or dendrites resulting from LASER beam stimulation.
The total absorption coefficient is a linear combination of the absorption coefficients of for instance blood, water and fat (hence for each component the value of that shown in figure 8 multiplied by its volume fraction). By fitting the above formula while using the power law for scattering we can determine the volume fractions of the blood, water and fat as well as the scattering coefficient. With this method we can now translate the measured spectra in physiological parameters that can be used to discriminate different tissues.
Another way to discriminate differences in spectra is by making use of a principal components analysis. This method allows classification of differences in spectra and thus allows discrimination between tissues. How to extract the intrinsic fluorescence from the measured fluorescence can be found for instance in Zhang et al., Optics Letters 25 (2000) p.1451.
In some further embodiments optical stimulation is performed by means of stimulating light-sensitive ionic channels like for example Channelrhodopsin-2, a light- sensitive cation channel that can be used to photo-stimulate mammalian neurons, e.g. see Nat Neurosci. 2005 Sep;8(9): 1263-8.
While the invention has been illustrated and described in detail in the drawings and foregoing description, such illustration and description are to be considered illustrative or exemplary and not restrictive; the invention is not limited to the disclosed embodiments. Other variations to the disclosed embodiments can be understood and effected by those skilled in the art in practicing the claimed invention, from a study of the drawings, the disclosure, and the appended claims. In the claims, the word "comprising" does not exclude other elements or steps, and the indefinite article "a" or "an" does not exclude a plurality. A single processor or other unit may fulfill the functions of several items recited in the claims. The mere fact that certain measures are recited in mutually different dependent claims does not indicate that a combination of these measures cannot be used to advantage. Any reference signs in the claims should not be construed as limiting the scope.
Claims
1. An apparatus for in vivo optical localization of a region of interest (ROI), the apparatus comprising:
an optical probe assembly;
at least one fist radiation source for generating an EM radiations beam, said at least one first radiation source optically coupled to said optical probe assembly, the probe being arranged to guide said radiation beam from said first radiation source towards said ROI, thereby providing illumination of said ROI;
at least one second radiation source for generating an EM radiations beam, said at least one second radiation source optically coupled to said optical probe assembly, the probe being arranged to guide said radiation beam from said second radiation source towards said ROI, thereby providing stimulation of said ROI;
at least one detector optically coupled to said optical probe assembly, the detector being arranged for detecting said ROI through the analysis of scattered or emitted radiation from said stimulated ROI.
2. An apparatus for in vivo optical localization of a ROI according to
claim 1 ,wherein said at least one second radiation source is a source for generating light amplified by stimulated emission of radiation (LASER) beams.
3. An apparatus for in vivo optical localization of a ROI according to claim 1, the apparatus further comprising one or more fluid transport means for delivering a fluid towards said ROI.
4. An apparatus for in vivo optical localization of a ROI according to claim 1, the apparatus further comprising:
a fluidic control unit for dispensing fluid towards said ROI, said fluidic control unit coupled to said optical probe assembly.
5. An apparatus for in vivo optical localization of a ROI according to claim 1 wherein said optical probe assembly comprises:
a housing comprising:
one or more optical guides for guiding EM radiations towards a ROI and/or for detecting EM radiations scattered or emitted from said ROI.
6. An apparatus for in vivo optical localization of a ROI according to claim 5 wherein said housing is or further comprises:
one or more fluid transport means for delivering a fluid towards said ROI.
7. An apparatus for in vivo optical localization of a ROI according to claim 5 wherein said one or more optical guides for guiding EM radiations comprises:
at least one optical guide for guiding EM radiations towards said ROI;
at least one optical guide for detecting EM radiations scattered or emitted from said ROI.
8. An apparatus for in vivo optical localization of a ROI according to claim 5 wherein said EM radiations are within the UV7 Vis, NIR wavelength range.
9. An apparatus for in vivo optical localization of a ROI according to claim 5 wherein said EM radiations are LASER beams.
10. An apparatus for in vivo optical localization of a ROI according to claim 5 wherein said one or more optical guides for guiding EM radiations comprises:
- at least one optical guide for guiding EM radiations in the UV7 Vis, NIR wavelength range towards said ROI and for guiding a LASER beam towards said ROI.
11. An apparatus for in vivo optical localization of a ROI according to claim 5 wherein said one or more optical guides for guiding EM radiations comprises:
- at least one optical guide for guiding EM radiations in the UV7 Vis, NIR wavelength range towards said ROI, and
at least one optical guide for guiding LASER beam towards said ROI.
12. An apparatus for in vivo optical localization of a ROI according to claim 1 wherein said ROI comprises nervous tissue.
13. An apparatus for in vivo optical localization of nervous tissue according to claim 5 said optical probe assembly further comprises at its distal end one or more lens systems.
14. A method for in vivo optical localization of nervous tissue, the method comprising:
localizing a nervous tissue by means of optical spectroscopy optically stimulating said nervous tissue by exposing said nervous tissue to a stimulating beam, such as a LASER beam or a narrow band light emitting diode (LED) beam,
detecting the presence of said stimulated nervous tissue by spectroscopic analysis of EM radiations emitted or scattered by said stimulated nervous tissue.
15. A method according to claim 14 wherein optically stimulating said nervous tissue comprises providing LASER light to perform treatment to said nervous tissue.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11158221 | 2011-03-15 | ||
EP11158221.9 | 2011-03-15 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2012123869A2 true WO2012123869A2 (en) | 2012-09-20 |
WO2012123869A3 WO2012123869A3 (en) | 2013-01-17 |
WO2012123869A9 WO2012123869A9 (en) | 2013-03-07 |
Family
ID=45875971
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2012/051111 WO2012123869A2 (en) | 2011-03-15 | 2012-03-09 | Device for optical nerve localization and optical nerve stimulation |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2012123869A2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016166067A1 (en) | 2015-04-17 | 2016-10-20 | Koninklijke Philips N.V. | Detection of anisotropic biological tissue |
US10231783B2 (en) | 2014-10-03 | 2019-03-19 | Covidien Lp | Energy-based surgical instrument including integrated nerve detection system |
CN110037784A (en) * | 2019-05-31 | 2019-07-23 | 山东威高医疗科技有限公司 | A kind of fixation bracket resetted for aids fracture based on electromagnetic navigation technology |
US10543041B2 (en) | 2014-10-03 | 2020-01-28 | Covidien Lp | Energy-based surgical instrument including integrated nerve detection system |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5284154A (en) | 1992-04-14 | 1994-02-08 | Brigham And Women's Hospital | Apparatus for locating a nerve and for protecting nerves from injury during surgery |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1639350A1 (en) * | 2003-06-19 | 2006-03-29 | Koninklijke Philips Electronics N.V. | Analysis apparatus and method comprising auto-focusing means |
WO2009032778A2 (en) * | 2007-08-29 | 2009-03-12 | Verathon Inc. | System and methods for nerve response mapping |
US7792334B2 (en) * | 2008-03-31 | 2010-09-07 | Immersion Corporation | Locating blood vessels |
US8565861B2 (en) * | 2008-05-02 | 2013-10-22 | Olympus Corporation | Optical inspection device, electromagnetic wave detection method, electromagnetic wave detection device, organism observation method, microscope, endoscope, and optical tomographic image generation device |
-
2012
- 2012-03-09 WO PCT/IB2012/051111 patent/WO2012123869A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5284154A (en) | 1992-04-14 | 1994-02-08 | Brigham And Women's Hospital | Apparatus for locating a nerve and for protecting nerves from injury during surgery |
Non-Patent Citations (5)
Title |
---|
J. BIOMED. OPT., vol. 15, pages 037015 |
NAT NEUROSCI., vol. 8, no. 9, September 2005 (2005-09-01), pages 1263 - 8 |
R. NACHABE, J. BIOMED. OPT., vol. 15, 2010, pages 037015 |
T.J. FARREL, MED. PHYS., vol. 19, 1992, pages 879 - 888 |
ZHANG ET AL., OPTICS LETTERS, vol. 25, 2000, pages 1451 |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10231783B2 (en) | 2014-10-03 | 2019-03-19 | Covidien Lp | Energy-based surgical instrument including integrated nerve detection system |
US10543041B2 (en) | 2014-10-03 | 2020-01-28 | Covidien Lp | Energy-based surgical instrument including integrated nerve detection system |
WO2016166067A1 (en) | 2015-04-17 | 2016-10-20 | Koninklijke Philips N.V. | Detection of anisotropic biological tissue |
US11202606B2 (en) | 2015-04-17 | 2021-12-21 | Koninklijke Philips N.V. | Detection of anisotropic biological tissue |
CN110037784A (en) * | 2019-05-31 | 2019-07-23 | 山东威高医疗科技有限公司 | A kind of fixation bracket resetted for aids fracture based on electromagnetic navigation technology |
Also Published As
Publication number | Publication date |
---|---|
WO2012123869A3 (en) | 2013-01-17 |
WO2012123869A9 (en) | 2013-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5214589B2 (en) | Tissue variation measurement using optical fiber | |
US20210204922A1 (en) | Diagnosis and treatment of tissue | |
JP5701615B2 (en) | Biopsy guidance with electromagnetic tracking and light needle | |
US8417323B2 (en) | Apparatus for depth-resolved measurements of properties of tissue | |
US20170173275A1 (en) | Optical sensor for needle-tip tissue identification and diagnosis | |
US9814449B2 (en) | Motorized optical imaging of prostate cancer | |
US20060173359A1 (en) | Optical apparatus for guided liver tumor treatment and methods | |
EP2814375B1 (en) | Photonic probe apparatus with integrated tissue marking facility | |
JP2010511463A (en) | Method for obtaining optical properties of tissue | |
JP2009504303A (en) | Combined technology and system using visual optics and passive infrared that can detect and identify cancer precursors, nevi and tumor on the skin, and can be used for early diagnosis | |
JP2008522697A (en) | Raman spectroscopic analysis of subsurface tissues and fluids | |
US20150157209A1 (en) | Biomedical detection apparatus | |
US20020049386A1 (en) | Multi-spectral fluorescence imaging and spectroscopy device | |
WO2012123869A2 (en) | Device for optical nerve localization and optical nerve stimulation | |
US11202606B2 (en) | Detection of anisotropic biological tissue | |
KR101166556B1 (en) | Fluorescence sensing probe and fluorescence sensing method using the same | |
RU2510248C2 (en) | Method for removing cerebral tumours with fluorescence diagnostics detection of tumour in combination with coagulation and aspiration and device for implementing it | |
Sroka et al. | Interstitial PDT in Brain Tumors-Investigations and Developments | |
Leblond et al. | Towards Depth-Resolved Fluorescence-Guided Surgery Using Multi-Spectral Near-Infrared Light | |
Wang et al. | Light Scattering Serves as Optical Signature for Detection of Positive Surgical Margins on prostate capsule |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12710119 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 12710119 Country of ref document: EP Kind code of ref document: A2 |